.
. taking ustekinumab�a biologic that targets a different aspect of the immune system," gelfand said.
.
.
.
.
.
"the drug must be administered at the right time point during development," he said.
. fueled by low vaccination rates led to 9,000 sick children and 10 infant deaths.